• Click here to request information on how your firm can be listed here.

• Class Action | Product Liability & Recalls | More..

On August 8, 2001 Bayer AG (the German-based manufacturer of Baycol) voluntarily recalled Baycol from the US market because of reports of sometimes fatal rhabdomyolysis, a severe muscle adverse reaction. Baycol (cerivastatin) was initially approved in the US in 1997 and is a member of a class of cholesterol-lowering drugs commonly referred to as "statins." Statins lower cholesterol levels by blocking a specific enzyme in the body that is involved in the synthesis of cholesterol.

More...

• Baycol Product Liability Litigation (MDL 1431)
• Baycol information from manufacturer, Bayer AG
• Baycol information, US Food and Drug Administration, Center for Drug Evaluation and Research
• Papers Indicate That Bayer Knew of Dangers of Its Cholesterol Drug, The New York Times, February 22, 2003
• Judge Criticizes Letter From Bayer, The New York Times, February 22, 2003
• Federal Court Orders Expedited Case Management Schedule in Baycol Products Litigation, MDL 1431, Baycol MDL 1431 Plaintiffs Steering Committee, March 4, 2002
• Baycol Pulled in Japan, CNN.com, August 23, 2001
• Baycol Linked to 52 Deaths, CNN.com, August 13, 2001
• FDA Talk Paper: Bayer Voluntarily Recalls Baycol, US Food and Drug Administration, August 8, 2001
• Bayer Pulls Key Drug, CNN.com, August 8, 2001
• Baycol Information (pre-recall), US Food and Drug Administration, MedWatch, 2001 Safety Information Summaries